Bone marrow

Changed by Frank Gaillard, 18 Apr 2024
Disclosures - updated 26 Oct 2023: Nothing to disclose

Updates to Article Attributes

Body was changed:

Normal boneBone marrow is divided into redubiquitous throughout the skeleton, primarily composed of haematopoietic cells and yellowfat cells between bony trabeculae and fibrous retinacula. It performs numerous physiological functions and dynamically changes during normal ageing and in response to stressors and pathology. Although bone marrow, a distinction made can be seen or inferred on the grounds of how much fat it containsmany imaging modalities, MRI is best able to visualise its constituents directly.

Gross anatomy

RedBone marrow is composed of contains:

  • haematopoietic cells

  • supporting stroma

  • reticulum (phagocytes and undifferentiated progenitor cells)

  • scattered fat cells

  • rich vascular supply

ConverselyAlthough all normal bone marrow contains the same constituents, the proportion of haematopoietic cells and fat varies dramatically depending on age and region. This allows normal bone marrow to be divided into red and yellow marrow based on how much fat it contains. 

Red marrow

Not only is red marrow is most abundant in infancy, occupying the entire skeleton (see below), but it is also contains composed primarily of haemopoeitc cells. At birth red marrow comprises of almost 100% haematopoietic cells. Over time this component reduces with increased contribution of fat cells such that by young adulthood the haematopoietic component has allreduced to 60% 10. By weight, the red marrow of adults is composed of 40% water, 40% fat and 20% protein 10.

Yellow marrow

Conversely yellow marrow, although having the same constituents as red, except thatis dominated by fat cells make up the vast majority (80(15% vs 40water, 80% in red marrowfat, 5% protein), with resulting poorlittle vascularity. Distribution varies with age and from one individual to another but should be symmetric10.

Normal marrow conversion

During infancy, red marrow occupies the entire ossified skeleton except for epiphyses and apophyses. Gradually, red marrow "retreats" centrally, such that by 25 years of age, it is essentially confined to the axial skeleton (pelvis, spine, shoulder girdle, skull). The conversion of red to yellow marrow progresses from distal to proximal of the extremities, so first hands and feet, then forearms/lower legs, then humeri/femora, then pelvis/spine.

Within the long bones, the epiphysis is the first to undergo conversion followed by the diaphysis before extending to the metadiaphysis 5,6.

AlsoAlthough the distribution varies with age and from one individual to another, islandsit should be symmetric.

Heterogeneous bone marrow signal is common and can be challenging to distinguish from pathology. Islands of red marrow may also be seen anywhere in the skeleton, typically in a subcortical distribution, often with central yellow marrow giving it a bull's eye' s-eye appearance on axial imaging. Additionally, red marrow is found in subchondral crescents,; typical locations include the proximal humerus and femur 2. Similarly, focal fatty deposits in bone marrow may be seen essentially anywhere within the skeleton.

Yellow marrow can also be seen focally within vertebral bodies. The pattern of normal red and yellow bone marrow distribution in vertebrathe spine is variable 9:

  • yellow marrow visible around the basivertebral veinveins (particularly common in younger patients, adjacentpredictably seen following regression of paediatric widespread red marrow)

  • band-like and triangular-like areas of yellow marrow in the vertebral body corners and abutting the endplates (adjacent to degenerative disc disease and Schmörl nodes, and within haemangiomas.

    Several patterns)

  • speckled pattern (punctate foci of normal red and yellow bone marrow distribution in the spine have been described by Ricci 9.)

  • ​​larger areas of yellow marrow and poorly circumscribed areas of red marrow

Radiographic features

MRI
  • T1

    • red marrow: hypointense to subcutaneous fat, but hyperintense to muscle and disc (due to scattered fat cells)

    • yellow marrow: hyperintense (follows the signal of subcutaneous fat)

  • T2

    • red marrow: slightly hyperintense to muscle, usually its signal intensity is slightly lower than that of yellow marrow, but sometimes it can be difficult to distinguish the two

    • yellow marrow: hyperintense to muscle and iso- to slightly hypointense to subcutaneous fat

  • STIR

    • red marrow: remains hyperintense

    • yellow marrow: is is saturated out (hypointense)

  • T1 C+ (Gd)

    • normal bone marrow in adults does not enhance visibly, whereas there may be a significant contrast enhancement in normal marrow of a neonate or a small child

    • enhancement in adults occurs only in pathological marrow, which can be accentuated on post-contrast images with fat saturation

Related pathology

Broadly,Bone marrow pathology can be divided into:demonstrate changes as a result of a very wide variety of pathologies, either due to direct involvement or as a response to disease elsewhere.

  1. proliferation

  2. depletion

  3. replacement

  4. vascular abnormalities

  5. miscellaneous

Marrow proliferation
Benign
Malignant

Most of the above conditions affect the marrow diffusely. The exception is multiple myeloma which has a predilection for focal deposits, and Waldenström macroglobulinaemia which causes infarcts.

The MRI appearance of pathological bone marrow is variable:

  • normal red marrow appearance (e.g. 10-25% of all leukaemic patients will have normal appearing marrow)

  • abnormal distribution of what appears to be normal red marrow

  • abnormal signal from red marrow in a normal distribution

  • abnormal signal and distribution

The abnormal signal is due to replacement of the small amounts of fat cells normally found in red marrow, such that T1 signal will decrease to or below the signal from disc or muscle. T2 signal is more variable, but will in general increase when compared to muscle.

Myelofibrosis and mastocytosis incite such prominent sclerosis that the marrow is very dark on both T1 and T2; a similar appearance to the marrow in haemosiderosis in patients with haemolysis from sickle cell disease and thalassaemia.

The leukaemias typically affect the metaphyses, then diaphyses, followed by the epiphyses. Changes in the latter indicate a large tumour load, and therefore has prognostic implications.

  • -<p>Normal <strong>bone marrow</strong> is divided into red and yellow marrow, a distinction made on the grounds of how much fat it contains. </p><h4>Gross anatomy</h4><p><strong>Red marrow</strong> is composed of:</p><ul>
  • +<p><strong>Bone marrow</strong> is ubiquitous throughout the skeleton, primarily composed of haematopoietic cells and fat cells between bony trabeculae and fibrous retinacula. It performs numerous physiological functions and dynamically changes during normal ageing and in response to stressors and pathology. Although bone marrow can be seen or inferred on many imaging modalities, MRI is best able to visualise its constituents directly.</p><h4>Gross anatomy</h4><p>Bone marrow contains:</p><ul>
  • -</ul><p>Conversely, <strong>yellow marrow </strong>has all the same constituents as red, except that fat cells make up the vast majority (80% vs 40% in red marrow), with resulting poor vascularity. Distribution varies with age and from one individual to another but should be symmetric.</p><h5>Normal marrow conversion</h5><p>During infancy red marrow occupies the entire ossified skeleton except for epiphyses and apophyses. Gradually red marrow "retreats" centrally, such that by 25 years of age it is essentially confined to the axial skeleton (pelvis, spine, shoulder girdle, skull). The conversion of red to yellow marrow progresses from distal to proximal of the extremities, so first hands and feet, then forearms/lower legs, then humeri/femora, then pelvis/spine.</p><p>Within the long bones, the epiphysis is the first to undergo conversion followed by the diaphysis before extending to the metadiaphysis <sup>5,6</sup>.</p><p>Also, islands of red marrow may be seen anywhere in the skeleton, typically in a subcortical distribution, often with central yellow marrow giving it a <a href="/articles/target-sign-disambiguation">bull's eye</a> appearance on axial imaging. Additionally, red marrow is found in subchondral crescents, typical locations include the proximal humerus and femur <sup>2</sup>.</p><p>Yellow marrow can also be seen focally in vertebra around the <a href="/articles/basivertebral-vein">basivertebral vein</a>, adjacent to <a href="/articles/degenerative-disc-disease">degenerative disc disease</a> and <a href="/articles/schmorl-nodes-3">Schmörl nodes</a>, and within <a href="/articles/haemangioma">haemangiomas</a>.</p><p>Several patterns of normal red and yellow <a href="/articles/patterns-of-normal-bone-marrow-distribution-in-the-spine">bone marrow distribution in the spine</a> have been described by Ricci <sup>9</sup>.</p><h4>Radiographic features</h4><h5>MRI </h5><ul>
  • +</ul><p>Although all normal bone marrow contains the same constituents, the proportion of haematopoietic cells and fat varies dramatically depending on age and region. This allows normal bone marrow to be divided into red and yellow marrow based on how much fat it contains.&nbsp;</p><h5>Red marrow</h5><p>Not only is red marrow is most abundant in infancy, occupying the entire skeleton (see below), but it is also contains composed primarily of haemopoeitc cells. At birth red marrow comprises of almost 100% haematopoietic cells. Over time this component reduces with increased contribution of fat cells such that by young adulthood the haematopoietic component has reduced to 60% <sup>10</sup>. <br><br>By weight, the red marrow of adults is composed of 40% water, 40% fat and 20% protein <sup>10</sup>.</p><h5>Yellow marrow</h5><p>Conversely yellow marrow, although having the same constituents as red, is dominated by fat (15% water, 80% fat, 5% protein) with little vascularity <sup>10</sup>.</p><h5>Normal marrow conversion</h5><p>During infancy, red marrow occupies the entire ossified skeleton except for epiphyses and apophyses. Gradually, red marrow "retreats" centrally, such that by 25 years of age, it is essentially confined to the axial skeleton (pelvis, spine, shoulder girdle, skull). The conversion of red to yellow marrow progresses from distal to proximal of the extremities, so first hands and feet, then forearms/lower legs, then humeri/femora, then pelvis/spine.</p><p>Within the long bones, the epiphysis is the first to undergo conversion followed by the diaphysis before extending to the metadiaphysis <sup>5,6</sup>.</p><p>Although the distribution varies with age and from one individual to another, it should be symmetric.</p><p><a href="/articles/heterogeneous-bone-marrow-signal" title="Heterogeneous bone marrow signal">Heterogeneous bone marrow signal</a> is common and can be challenging to distinguish from pathology. Islands of red marrow may also be seen anywhere in the skeleton, typically in a subcortical distribution, often with central yellow marrow giving it a bull' s-eye appearance on axial imaging. Additionally, red marrow is found in subchondral crescents; typical locations include the proximal humerus and femur <sup>2</sup>. Similarly, focal fatty deposits in bone marrow may be seen essentially anywhere within the skeleton. </p><p>Yellow marrow can also be seen focally within vertebral bodies. The pattern of normal red and yellow bone marrow distribution in the spine is variable <sup>9</sup>:</p><ul>
  • +<li><p>yellow marrow visible around the <a href="/articles/vertebral-venous-plexus-1" title="Basivertebral veins">basivertebral veins</a> (particularly common in younger patients, predictably seen following regression of paediatric widespread red marrow)</p></li>
  • +<li><p>band-like and triangular-like areas of yellow marrow in the vertebral body corners and abutting the endplates (adjacent to <a href="/articles/degenerated-disc-1">degenerative disc disease</a> and <a href="/articles/schmorl-nodes-3">Schmörl nodes</a>)</p></li>
  • +<li><p>speckled pattern (punctate foci of red and yellow bone marrow)</p></li>
  • +<li><p>​​larger areas of yellow marrow and poorly circumscribed areas of red marrow</p></li>
  • +</ul><h4>Radiographic features</h4><h5>MRI&nbsp;</h5><ul>
  • -<li><p>red marrow: slightly hyperintense to muscle, usually its signal intensity is slightly lower than that of yellow marrow, but sometimes it can be difficult to distinguish the two </p></li>
  • +<li><p>red marrow: slightly hyperintense to muscle, usually its signal intensity is slightly lower than that of yellow marrow, but sometimes it can be difficult to distinguish the two&nbsp;</p></li>
  • -<li><p>yellow marrow: is saturated out (hypointense)</p></li>
  • +<li><p>yellow marrow:&nbsp;is saturated out (hypointense)</p></li>
  • -</ul><h4>Related pathology</h4><p>Broadly, marrow pathology can be divided into:</p><ol>
  • -<li><p>proliferation</p></li>
  • -<li><p>depletion</p></li>
  • -<li><p>replacement</p></li>
  • -<li><p>vascular abnormalities</p></li>
  • -<li><p>miscellaneous</p></li>
  • -</ol><h5>Marrow proliferation</h5><h6>Benign</h6><ul>
  • -<li><p><a href="/articles/myelodysplastic-syndrome">myelodysplastic syndrome</a></p></li>
  • -<li><p><a href="/articles/polycythaemia-rubra-vera">polycythaemia vera</a></p></li>
  • -<li><p><a href="/articles/primary-myelofibrosis">myelofibrosis</a></p></li>
  • -<li><p><a href="/articles/bone-marrow-reconversion">reconversion of yellow to red marrow</a></p></li>
  • -<li><p><a href="/articles/mastocytosis">mastocytosis</a></p></li>
  • -</ul><h6>Malignant</h6><ul>
  • -<li><p><a href="/articles/leukaemia">leukaemia</a></p></li>
  • -<li>
  • -<p>plasma cell dyscrasias</p>
  • -<ul>
  • -<li><p><a href="/articles/multiple-myeloma-1">multiple myeloma</a></p></li>
  • -<li><p>primary <a href="/articles/amyloidosis">amyloidosis</a></p></li>
  • -</ul>
  • -</li>
  • -<li><p>monoclonal gammopathies, e.g. <a href="/articles/monoclonal-gammopathy-of-undetermined-significance">monoclonal gammopathy of unknown significance</a> (MGUS)</p></li>
  • -<li><p><a href="/articles/waldenstrom-macroglobulinaemia" title="Waldenström macroglobulinaemia">Waldenström macroglobulinaemia</a></p></li>
  • -<li><p><a href="/articles/post-transplant-lymphoproliferative-disorder-2" title="PTLD">lymphoproliferative disorder</a></p></li>
  • -</ul><p>Most of the above conditions affect the marrow diffusely. The exception is <a href="/articles/multiple-myeloma-1">multiple myeloma</a> which has a predilection for focal deposits, and <a href="/articles/waldenstrom-macroglobulinaemia" title="Waldenström macroglobulinaemia">Waldenström macroglobulinaemia</a> which causes infarcts.</p><p>The MRI appearance of pathological bone marrow is variable:</p><ul>
  • -<li><p>normal red marrow appearance (e.g. 10-25% of all leukaemic patients will have normal appearing marrow)</p></li>
  • -<li><p>abnormal distribution of what appears to be normal red marrow</p></li>
  • -<li><p>abnormal signal from red marrow in a normal distribution</p></li>
  • -<li><p>abnormal signal and distribution</p></li>
  • -</ul><p>The abnormal signal is due to replacement of the small amounts of fat cells normally found in red marrow, such that T1 signal will decrease to or below the signal from disc or muscle. T2 signal is more variable, but will in general increase when compared to muscle.</p><p><a href="/articles/primary-myelofibrosis">Myelofibrosis</a> and <a href="/articles/mastocytosis">mastocytosis</a> incite such prominent sclerosis that the marrow is very dark on both T1 and T2; a similar appearance to the marrow in <a href="/articles/haemosiderosis">haemosiderosis</a> in patients with <a href="/articles/haemolysis">haemolysis</a> from <a href="/articles/sickle-cell-disease">sickle cell disease</a> and <a href="/articles/thalassaemia">thalassaemia</a>.</p><p>The leukaemias typically affect the metaphyses, then diaphyses, followed by the epiphyses. Changes in the latter indicate a large tumour load, and therefore has prognostic implications.</p>
  • +</ul><h4>Related pathology</h4><p>Bone marrow can demonstrate changes as a result of a very wide variety of pathologies, either due to direct involvement or as a response to disease elsewhere. </p><ul>
  • +<li><p><a href="/articles/bone-marrow-oedema" title="Bone marrow oedema">bone marrow oedema</a></p></li>
  • +<li><p><a href="/articles/bone-marrow-reconversion" title="Bone marrow reconversion">bone marrow conversion</a></p></li>
  • +<li><p><a href="/articles/bone-metastases-1" title="Bone metastases">bone metastases</a></p></li>
  • +<li><p><a href="/articles/primary-intraosseous-haemangioma" title="Haemangiomas of bone">haemangiomas of bone</a></p></li>
  • +<li><p><a href="/articles/myeloproliferative-neoplasm-1" title="Myeloproliferative neoplasms">myeloproliferative neoplasms</a> (see <a href="/articles/who-classification-of-haematolymphoid-tumours" title="WHO classification of haematolymphoid tumours">WHO classification of haematolymphoid tumours</a>)</p></li>
  • +<li><p><a href="/articles/myelodysplastic-syndrome" title="Myelodysplastic syndromes (MDS's) ">myelodysplastic syndromes</a></p></li>
  • +<li><p><a href="/articles/serous-atrophy-of-bone-marrow-1" title="Serous atrophy of bone marrow">serous atrophy of bone marrow</a></p></li>
  • +</ul>

References changed:

  • 10. Guillerman R. Marrow: Red, Yellow and Bad. Pediatr Radiol. 2013;43 Suppl 1(S1):S181-92. <a href="https://doi.org/10.1007/s00247-012-2582-0">doi:10.1007/s00247-012-2582-0</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/23478934">Pubmed</a>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.